Systemic Inflammation and Activation of Haemostasis Predict Poor Prognosis and Response to Chemotherapy in Patients with Advanced Lung Cancer

Systemic inflammation and activation of haemostasis are common in patients with lung cancer. Both conditions support tumour growth and metastasis. Therefore, inflammatory and haemostatic biomarkers might be useful for prediction of survival and therapy response. Patients with unresectable/metastatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Moik, Florian, Zöchbauer-Müller, Sabine, Posch, Florian, Pabinger, Ingrid, Ay, Cihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352812/
https://www.ncbi.nlm.nih.gov/pubmed/32570944
http://dx.doi.org/10.3390/cancers12061619

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352812/
https://www.ncbi.nlm.nih.gov/pubmed/32570944
http://dx.doi.org/10.3390/cancers12061619

Ejemplares similares